Licochalcone A regulates hepatic lipid metabolism through activation of AMP-activated protein kinase

Fitoterapia

Volumn 86, Issue 1, 2013, Pages 208-216

  Quan, Hai Yan ^a   Kim, Soo Jung ^a   Kim, Do Yeon ^a   Jo, Hee Kyung ^a   Kim, Go Woon ^a   Chung, Sung Hyun ^a  

^a Kyung Hee University   (South Korea)

Author keywords

AMP activated protein kinase; HepG2 cells; High fat diet; Licochalcone A; Mitochondrial respiration; Sterol regulatory element binding protein

Indexed keywords

ADENOSINE TRIPHOSPHATE; GLYCEROL 3 PHOSPHATE ACYLTRANSFERASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LICOCHALCONE A; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRIACYLGLYCEROL;

ANIMAL CELL; ARTICLE; CELL STRAIN HEPG2; DYSLIPIDEMIA; ENZYME ACTIVATION; FATTY ACID TRANSPORT; FATTY LIVER; HUMAN; HUMAN CELL; HYPERGLYCEMIA; HYPERINSULINEMIA; IN VITRO STUDY; IN VIVO STUDY; INSULIN RESISTANCE; LIPID DIET; LIPID LIVER LEVEL; LIPID METABOLISM; LIPID STORAGE; LIPOGENESIS; LIPOLYSIS; MITOCHONDRIAL RESPIRATION; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADENOSINE TRIPHOSPHATE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BIOLOGICAL TRANSPORT; CHALCONES; DIET, HIGH-FAT; DIETARY FATS; ENZYME ACTIVATION; GENE EXPRESSION; GLYCYRRHIZA; HEP G2 CELLS; HUMANS; LIPID METABOLISM; LIVER; MICE; MICE, INBRED ICR; MITOCHONDRIA; OXYGEN CONSUMPTION; PLANT EXTRACTS; SIGNAL TRANSDUCTION; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRIGLYCERIDES;

ANIMALIA; GLYCYRRHIZA; MUS;

EID: 84876369786     PISSN: 0367326X     EISSN: 18736971     Source Type: Journal    
DOI: 10.1016/j.fitote.2013.03.005     Document Type: Article

References (28)

1. B.A. Neuschwander-Tetri, and S.H. Caldwell Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference Hepatology 37 2003 1202 1219
2. B.W. Smith, and L.A. Adams Non-alcoholic fatty liver disease Crit Rev Clin Lab Sci 48 2011 97 113
3. P. Tessari, A. Coracina, A. Cosma, and A. Tiengo Hepatic lipid metabolism and non-alcoholic fatty liver disease Nutr Metab Cardiovasc Dis 19 2009 291 302
4. J.B. Moor Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome Proc Nutr Soc 69 2010 211 220
5. L. Pacifico, V. Nobili, C. Anania, P. Verdecchia, and C. Chiesa Pediatric nonalcoholic fatty live disease, metabolic syndrome and cardiovascular risk World J Gastroenterol 17 2011 3028 3091
6. G.R. Steinberg, and B.E. Kemp AMPK in health and disease Physiol Rev 89 2009 1025 1078
7. G. Musso, R. Gambio, and M. Cassader Emerging molecular targets for the treatment of nonalcoholic fatty liver disease Annu Rev Med 61 2010 375 392
8. S.N. Kim, S.J. Bae, H.B. Kwak, Y.K. Min, S.H. Jung, and C.H. Kim In vitro and in vivo osteogenic activity of licochalcone A Amino Acids 42 2012 1455 1465
9. L. Kolbe, J. Immeyer, J. Batzer, U. Wensorra, K. tom Dieck, and C. Mundt Anti-inflammatory efficacy of licochalcone A: correlation of clinical potency and in vitro effects Arch Dermatol Res 298 2006 23 30
10. M. Funakoshi-Tago, K. Nakamura, R. Tsuruya, M. Hatanaka, T. Mashino, and Y. Sonoda The fixed structure of licochalcone A by alpha, beta-unsaturated ketone is necessary for anti-inflammatory activity through the inhibition of NF-kappaB activation Int Immunopharmacol 10 2010 562 571
11. F. Mi-Ichi, H. Miyadera, T. Kobayashi, S. Takamiya, S. Waki, and S. Iwata Parasite mitochondria as a target of chemotherapy: inhibitory effect of licochalcone A on the Plasmodium falciparum respiratory chain Ann N Y Acad Sci 1056 2005 46 54
12. C. Messier, and D. Grenier Effect of licorice compounds licochalcone A, glabridin and glycyrrhizic acid on growth and virulence properties of Candida albicans Mycoses 54 2011 e801 e806
13. Y.H. Kim, E.K. Shin, D.H. Kim, H.H. Lee, J.H. Park, and J.K. Kim Antiangiogenic effect of licochalcone A Biochem Pharmacol 80 2010 1152 1159
14. G. Yoon, B.Y. Kang, and S.H. Cheon Topoisomerase I inhibition and cytotoxicity of licochalcones A and E from Glycyrrhiza inflata Arch Pharm Res 30 2007 313 316
15. Y.S. Lee, S.H. Kim, S.H. Jung, J.K. Kim, C.H. Pan, and S.S. Lim Aldose reductase inhibitory compounds from Glycyrrhiza uralensis Biol Pharm Bull 33 2010 917 921
16. Z.J. Xu, J.G. Fan, X.D. Ding, L. Qiao, and G.L. Wang Characterization of high-fat, diet-induced, non-alcoholic steatohepatitis with fibrosis in rats Dig Dis Sci 55 2010 931 940
17. Y. Piao, H.G. Kim, M.S. Oh, and Y.K. Pak Overexpression of TFAM, NRF-1 and myr-AKT protects the MPP(+)-induced mitochondrial dysfunctions in neuronal cells Biochim Biophys Acta 2012 1820 577 585
18. S.Y. Ahn, Y.S. Choi, H.J. Koo, J.H. Jeong, W.H. Park, and M. Kim Mitochondrial dysfunction enhances the migration of vascular smooth muscles cells via suppression of Akt phosphorylation Biochim Biophys Acta 2010 1800 275 281
19. Y. Li, S. Xu, M.M. Mihaylova, B. Zheng, X. Hou, and B. Jiang AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice Cell Metab 13 2011 376 388
20. T. Saitoh, and S. Shibata New type chalcones from licorice root Tetrahedron Lett 16 1975 4461 4462
21. G. Yoon, Y.D. Jung, and S.H. Cheon Cytotoxic allyl retrochalcone from the roots of Glycyrrhiza inflata Chem Pharm Bull 53 2005 694 695
22. H.G. Park, E.J. Bak, G.H. Woo, J.M. Kim, Z. Quan, and J.M. Kim Licochalcone E has an antidiabetic effect J Nutr Biochem 23 2012 759 767
23. E.M. Brunt Pathology of nonalcoholic fatty liver disease Nat Rev Gastroenterol Hepatol 7 2010 195 203
24. M.M. Richardson, J.R. Jonsson, E.E. Powell, E.M. Brunt, B.A. Neuschwander-Tetri, and P.S. Bhathal Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction Gastroenterology 133 2007 80 90
25. M.J. Sanders, P.O. Grondin, B.D. Hegarty, M.A. Snowden, and D. Carling Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade Biochem J 403 2007 139 148
26. T. Kosaka, R. Okuyama, W. Sun, T. Ogata, J. Harada, and K. Araki Identification of molecular target of AMP-activated protein kinase activator by affinity purification and mass spectrometry Anal Chem 77 2005 2050 2055
27. D. Konrad, A. Rudich, P.J. Bilan, N. Patel, C. Richardson, and L.A. Witters Troglitazone causes acute mitochondrial membrane depolarisation and an AMPK-mediated increase in glucose phosphorylation in muscle cells Diabetologia 48 2005 954 966
28. M.R. Owen, E. Doran, and A.P. Halestrap Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain Biochem J 348 2000 607 614